I traded in and out of this stock three months ago. I only held it one day after reading the CEO had been arrested in Fort Lauderdale years ago on some traffic or driving charge. It just didn't stick well with me.
The drop-off in sales is being blamed in large part on Valeant Pharmaceuticals' (NYSE:VRX) failure to pay contractual royalties to PDL BioPharma during the quarter on sales of Glumetza, a drug Valeant acquired when it bought Salix Pharmaceuticals. Valeant Pharmaceuticals reported Glumetza sales of $53 million last quarter, but, according to PDL BioPharma, it failed to provide monthly reports or make any payments to PDL BioPharma until late October
the SECX head said this week that short sellers had gotten their attention.....you certainly have mine! Thanks for the cheap shares.....p/e = 7 ev/ebit = 5
APC is largest gas producer in Utah. STR has pipelines and 900,000 gas utility customers in Utah.....This isn't as big an idea as APA, but it is cash flow positive w/o billions in outstanding offshore drill rig contracts
I just looked at Rax's Q3 report....they had net income of $75M in 9 months with interest payment cost of $1.5M.....#$%$? Why would you balloon your interest payments to $32 million?????